AN
Alto Neuroscience
ANRO·NYSELos Altos CAFounded 201950 employees
Small CapbiotechPublicCNS
Platform: ALTO-100 MDD
Market Cap
$0.6B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (ANRO)
Loading ANRO stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ANR-8751 | ANR-8751 | Phase 2/3 | 2 | CDK2 | MDDWilms | ||
| Ceviosocimab | ANR-6321 | Preclinical | 2 | WEE1 | PBCWM |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)